What We Treat

For children fighting high-risk, recurrent or hard-to-treat neuroblastoma or pheochromocytoma, the options can be limited. MIBG therapy can offer hope.

What is I-131 MIBG treatment?

I-131 MIBG is a treatment that uses radio-labeled iodine molecules (I-131) attached to a compound called metaiodobenzylguanidine (MIBG). I-131 MIBG specifically targets tumors like neuroblastoma and pheochromocytoma. It is taken up by these tumors and delivers a higher dose of radiation directly to the tumor while preserving normal adjacent tissue.

Services We Offer

A safe, comforting place for healing

After a child receives MIBG treatment, he is radioactive for about up to seven days. He must stay in a special room and minimize contact with parents and siblings, and avoid contact with other patients.

We understand how important it is to be close to your child while he is in the hospital. That is why we specially designed a separate room where parents can stay that is adjacent to the child’s room.

The two rooms are equipped with a closed-circuit TV system that allows the child and his parents to stay connected at all times. Families can see, talk, watch movies and play video games together via our specialized close-circuit TV system. A parent can still go in to the patient’s room, but this unique parent-room set up helps decrease radiation exposure to the family.

Additional features of our MIBG facility includes:

  • Lead lined walls to prevent unnecessary exposure to radiation
  • Clear shields to protect family members, doctors and nurses from the radiation while still being able to see the child
  • Paper and plastic coverings on all walls, flooring and other surfaces

For more information or to schedule a referral (physicians), call 888-785-1112 or 404-785-1112.

Find a clinical trial